Core Insights - Solésence, Inc. is undergoing a strategic transformation aimed at enhancing innovation, product quality, and operational efficiency while expanding its market reach in skin care, sun care, and color cosmetics [3][6]. Financial Performance - Revenue for Q3 2025 was $14.5 million, a decrease from $16.9 million in Q3 2024, reflecting a year-over-year decline of approximately 14% [9]. - Gross margin for Q3 2025 was 23%, down from 36% in the same quarter of 2024, indicating a significant reduction in profitability [9]. - Gross profit for Q3 2025 was $3.4 million, compared to $6.1 million in Q3 2024, marking a decline of about 44% [9]. - The company reported a net loss of $1.1 million for Q3 2025, contrasting with a net income of $3.0 million in Q3 2024 [9]. Operational Highlights - The company has consolidated its manufacturing facilities from three to two, aiming to improve operational efficiencies [9]. - Recent structural changes include unifying R&D and Quality teams and increasing production automation to enhance productivity [6][9]. - The appointment of Laura Riffer as CFO and the promotion of Kevin Cureton to CEO are part of the leadership changes to support the company's strategic initiatives [8]. Strategic Initiatives - Solésence is focused on driving future innovation and growth through key leadership changes and operational restructuring [3][8]. - The company aims to solidify its position as a long-term partner for brand partners by delivering high-quality products efficiently [6].

Core Insights - Solésence, Inc. will report its third quarter 2025 results on November 11, 2025, before market opening [1] - The company will host a conference call and webcast on the same date to discuss the results [1] Conference Call Details - The conference call is scheduled for November 11, 2025, at 7:30 a.m. CDT, 8:30 a.m. EDT [2] - Key speakers will include Kevin Cureton (President & CEO), Laura Riffner (Chief Financial Officer), and Jess Jankowski (Board Advisor) [2] - Access to the call can be obtained through a registration link, which provides a personalized PIN for dial-in [2][3] Company Overview - Solésence, Inc. is recognized for its scientifically-driven health care solutions in beauty and life science categories [4] - The company focuses on innovation, inclusivity, and the science of beautiful skin, particularly in mineral-based sun protection [4] - Solésence aims to integrate protection, prevention, and treatment technologies into daily use products, enhancing skin health and self-care [4]

Leadership Changes - Solésence, Inc. has announced the promotion of Kevin Cureton to President and Chief Executive Officer, with Laura Riffner appointed as Chief Financial Officer, and Jess Jankowski transitioning to Board Advisor [1][2] - These leadership changes are part of a broader strategic transformation aimed at enhancing the company's operational efficiency and market presence [2] Company Rebranding and Growth - In the first half of 2025, Solésence rebranded from Nanophase Technologies, reflecting the success of its Beauty Science platform and reinforcing its mission to deliver joy through innovation and inclusivity [2] - The company uplisted to Nasdaq on April 8, 2025, which has increased visibility with the investment community and is expected to drive greater shareholder value [2] Strategic Vision and Future Plans - The leadership transition is seen as a pivotal moment for Solésence, with a focus on delivering high-performance skin care, sun care, and color cosmetics products to consumers worldwide [2][3] - Kevin Cureton's leadership is expected to foster continued growth and innovation, while Laura Riffner's extensive financial experience will enhance operational excellence [3] Executive Experience - Laura Riffner brings over 35 years of experience in finance management and strategic planning, having previously served as CFO at Nagase America and Paxton/Patterson, where she improved operational efficiencies and financial forecasting [3][4]

Core Insights - Solésence, Inc. reported a strong financial performance for Q2 2025, with a revenue increase of 56% year-over-year, reaching a record $20.4 million compared to $13.0 million in Q2 2024 [10] - The company emphasized its commitment to innovation and effective commercial execution, which has attracted leading brands to partner with them [2][5] - Solésence expanded its debt facilities to enhance financial flexibility, increasing borrowing capacity from $14.2 million to $23.0 million, and extending loan maturity dates [10] Financial Results - Revenue for Q2 2025 was $20.4 million, a 56% increase from $13.0 million in Q2 2024 [10] - Gross profit for the quarter was $5.9 million, up from $3.7 million in the same period last year [10] - Net income for Q2 2025 was $2.7 million, compared to $0.9 million in Q2 2024, which included an Employee Retention Credit net receipt of approximately $1.2 million [10] Operational Highlights - Shipment volume increased by 102% year-over-year, while production volume rose by 127% year-over-year [10] - The company improved its gross margin sequentially from the first quarter, maintaining a gross margin of 29% [10][5] - Solésence achieved record unit volume during its peak demand season, reflecting effective operational management [5] Strategic Initiatives - The company amended its loan agreements to support long-term growth initiatives, enhancing its financial flexibility [10] - Solésence's focus on innovation is central to its value proposition, aiming to equip partners with differentiated consumer products [2]

Core Insights - Solésence, Inc. will report its second quarter 2025 results on July 31, 2025, after market close [1] - The company will host a conference call and webcast on the same date to discuss the results [1] Conference Call Details - The conference call is scheduled for July 31, 2025, at 4:00 p.m. CDT, 5:00 p.m. EDT [2] - Speakers will include Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer [2] - Registration is required to receive the dial-in number and personalized PIN for the call [2][3] Company Overview - Solésence, Inc. is a leader in scientifically-driven health care solutions in beauty and life science categories [4] - The company focuses on innovation, inclusivity, and the science of beautiful skin, particularly in mineral-based sun protection [4] - Solésence integrates protection, prevention, and treatment technologies into daily use products, enhancing skin health solutions [4]

Core Insights - Solésence, Inc. has amended its loan agreements to increase borrowing capacity and extend maturity dates, enhancing financial flexibility for strategic objectives [1][2][3] Financial Details - The maximum borrowing capacity has increased from $14.2 million to $23.0 million, with maturity dates extended from October 1, 2025, to April 30, 2027 [2] Strategic Objectives - The additional borrowing capacity will support procurement of key raw materials, improve lead times for packaging and product launches, and empower brand partners to drive product adoption [3] Leadership Commentary - The President and CEO of Solésence emphasized that the increased financial capacity and extended timeline will be crucial for scaling operations and serving brand partners effectively [4]

Core Insights - Solésence, Inc. reported record revenue of $14.6 million for Q1 2025, a 48% increase from $9.9 million in Q1 2024, driven by strong sales and large customer orders [7][2] - The company experienced a significant increase in shipment volume by 95% year-over-year and production volume by 120% year-over-year, indicating robust operational growth [7][2] - Solésence has successfully uplisted to Nasdaq under the ticker "SLSN," enhancing its visibility in the investment community [6][2] Financial Performance - Revenue for Q1 2025 was $14.6 million, up from $9.9 million in Q1 2024, marking a 48% increase [7] - Gross profit decreased to $3.3 million in Q1 2025 from $3.6 million in Q1 2024, resulting in a gross margin of 23%, down from 36% in the previous year [7] - Net income for Q1 2025 was breakeven, compared to a net income of $0.9 million in Q1 2024 [7] Operational Highlights - The company launched a multi-SKU product line for a new strategic brand partner, which incurred one-time start-up costs affecting gross margins [2] - Solésence anticipates continued sequential revenue growth with current shipped and open orders exceeding $45 million [2] - The company has expanded its intellectual property portfolio with new technology allowances in Japan, South Korea, and Mexico [7] Future Outlook - Management expects substantial improvement in gross margin levels as operations scale and fixed manufacturing costs are managed more efficiently [2] - The company aims to capitalize on significant opportunities to drive long-term shareholder value following its Nasdaq uplisting and rebranding efforts [2]

Core Viewpoint - Solésence, Inc. will report its first quarter 2025 results on May 5, 2025, and will host a conference call and webcast on the same day [1]. Group 1: Conference Call Details - The conference call is scheduled for May 5, 2025, at 4:00 p.m. CDT (5:00 p.m. EDT) [2]. - Speakers for the call will include Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer [2]. - Participants must register to receive the dial-in number and personalized PIN [2]. Group 2: Company Overview - Solésence, Inc. is a leader in scientifically-driven health care solutions in beauty and life science categories [4]. - The company's mission focuses on delivering joy through innovation, inclusivity, and the science of beautiful skin [4]. - Solésence has redefined mineral-based sun protection by enhancing transparency, effectiveness, aesthetics, and wearability [4].